Enrico Morello, Sara Roversi, Giulia Brambilla, Liana Signorini, Marianna Lorenzoni, Marco Andreoli, Simona Bernardi, Michele Malagola, Mirko Farina, Vera Radici, Gabriele Magliano, Simona Fiorentini, Arnaldo Caruso, Domenico Russo
The rise of Vancomycin-resistant enterococci (VRE) strains among cellular therapy recipients raises concerns due to increased morbidity, mortality, and hospitalization costs, particularly impacting transplanted patients with diminished survival expectations. Recent research linking lactose to Enterococcus growth and graft-versus-host disease (GVHD) emphasizes the need for data on reducing lactose in the diets of VRE-carrying patients, especially in cellular therapy contexts like CAR-T or allogeneic hematopoietic stem cell transplantation...
March 7, 2024: Transplantation and cellular therapy